1. "Ferrata Storti Foundation"
Formats
  1. Meeting Abstract (178)
  2. Journal Article (122)
  3. Research Letter (25)
  4. Editorial (15)
  5. Review (10)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (294)
  2. Hematologic Malignancies, Division of (292)
  3. Center for Hematologic Malignancies (269)
  4. Adult Leukemia (106)
  5. Lymphoma (73)
  6. GSK Faculty (70)

More Groups

People
  1. Carl Landgren (25)
  2. Andrew Zelenetz (24)
  3. Martin Tallman (24)
  4. Ross Levine (24)
  5. Michael Mauro (21)
  6. Anas Younes (16)

More People

Years
  1. 2025 (12)
  2. 2024 (23)
  3. 2023 (17)
  4. 2022 (20)
  5. 2021 (13)
  6. 2020 (18)

More Years

Publications
  1. Haematologica (348)
  2. Haematologica Meeting Reports (4)
Publishers
  1. Ferrata Storti Foundation (352)

Results (352)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dasatinib is associated with durable treatment responses in chronic phase chronic myeloid leukemia: Long-term follow-up from the phase I trial (Ca180002)
    Meeting Abstract

    Cortes, J.; Sawyers, C. L.; Kantarjian, H. M.; Shah, N. P.; Paquette, R.; Bleickardt, E.; Paliwal, P.; Talpaz, M.
    Haematologica (2008)

    Fulltext@MSK | Save
  • Pha-739358: A pan-aurora kinase inhibitor
    Journal Article

    Paquette, R.; Shah, N.; Sawyers, C.; Martinelli, G.; Nicoll, J.; Chalukya, M.; Locatelli, G.; Capolongo, L.; Moll, J.; Comis, S.; more...
    Haematologica Meeting Reports (2008)

    Fulltext@MSK | Save
  • Towards the genetic treatment of β-thalassemia: New disease models, new vectors, new cells
    Journal Article

    Moi, P.; Sadelain, M.
    Haematologica (2008)

    Fulltext@MSK | Save
  • A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1)
    Journal Article

    Liso, A.; Castiglione, F.; Cappuccio, A.; Stracci, F.; Schlenk, R. F.; Amadori, S.; Thiede, C.; Schnittger, S.; Valk, P. J. M.; Döhner, K.; more...
    Haematologica (2008)

    Fulltext@MSK | Save
  • CD32B in multiple myeloma and systemic AL-amyloidosis
    Meeting Abstract

    Boruchov, A. M.; Zhou, P.; Olshen, A.; Rankin, C.; Bonvini, E.; Koenig, S.; Fleisher, M.; McKenzie, S.; Maslak, P.; Jhanwar, S.; more...
    Haematologica (2007)

    Fulltext@MSK | Save
  • Calreticulin, AL-amyloidosis and high-dose melphalan
    Meeting Abstract

    Zhou, P.; Teruya-Feldstein, J.; Lu, P.; Clark, B.; Fleisher, M.; Olshen, A.; Comenzo, R. L.
    Haematologica (2007)

    Fulltext@MSK | Save
  • Novel Cdk4/6-based combination therapies in myeloma
    Meeting Abstract

    Huang, X.; Louie, T.; Xiao, D.; Di Liberto, M.; Toogood, P. L.; Chen, I.; Niesvizky, R.; Moore, M. A. S.; Chen-Kiang, S.
    Haematologica (2007)

    Fulltext@MSK | Save
  • Long-term outcome of survivors of autologous hematopoietic-cell transplantation for refractory and relapsed Hodgkin lymphoma
    Meeting Abstract

    Goodman, K. A.; Riedel, E.; Serrano, V.; Gonzales, A. M.; Gulati, S.; Moskowitz, C.; Yahalom, J.
    Haematologica (2007)

    Fulltext@MSK | Save
  • The role of high-dose therapy in AL-amyloidosis
    Meeting Abstract

    Comenzo, R. L.
    Haematologica (2007)

    Fulltext@MSK | Save
  • Nursing guidelines for enhanced patient care
    Meeting Abstract

    Bertolotti, P.; Bilotti, E.; Colson, K.; Curran, K.; Doss, D.; Faiman, B.; Gavino, M.; Jenkins, B.; Lilleby, K.; Love, G.; more...
    Haematologica (2007)

    Fulltext@MSK | Save